![Ad W. van Gorp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ad W. van Gorp
Directeur Général chez Cytura Therapeutics BV
Provenance du réseau au premier degré de Ad W. van Gorp
Entité | Type d'entité | Industrie | |
---|---|---|---|
University of Utrecht
9
| College/University | Other Consumer Services | 9 |
Cytura Therapeutics BV
![]() Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ad W. van Gorp via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
AGENUS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Nyenrode Business Universiteit | College/University | Graduate Degree | |
HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ciclofilin Pharmaceuticals, Inc.
![]() Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Pharmaceuticals: Other | Director/Board Member | |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
AFC AJAX NV | Recreational Products | Director/Board Member | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Director/Board Member | |
Maastricht University | College/University | Doctorate Degree | |
University of Tilburg | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Chief Tech/Sci/R&D Officer | |
University of Twente | College/University | Doctorate Degree | |
University of Groningen | College/University | Doctorate Degree | |
Vrije Universiteit Amsterdam | College/University | Corporate Officer/Principal | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
Genmab, Inc.
![]() Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
University Medical Center of Utrecht | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Organon Biosciences, Inc. | Corporate Officer/Principal | ||
ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
InteRNA Technologies BV
![]() InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Stichting Cito Instituut Voor Toetsontwikkeling | Investment Trusts/Mutual Funds | Director/Board Member | |
TiasNimbas Business School BV | College/University | Doctorate Degree | |
Berenschot Groep BV
![]() Berenschot Groep BV Miscellaneous Commercial ServicesCommercial Services Berenschot Groep BV provides legal services. It offers services in the areas of additive manufacturing, benchmarking, business operations, change management, corporate social responsibility/sustainability, facility management, information management, leadership development, mergers and acquisitions, operational excellence, organizational design and structuring, organizational development, performance management, job evaluation and remuneration, policy research and evaluation, project grants, recovery and restructuring, and strategy formulation, as well as process, project and program management. The company was founded in 1938 and is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
Atheneos Ventures LLC
![]() Atheneos Ventures LLC Investment ManagersFinance Atheneos Ventures LLC (Atheneos Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Santa Clara, California. | Investment Managers | Private Equity Investor | |
ABN AMRO BANK N.V. | Major Banks | Compliance Officer Chairman | |
Netherlands Ministry of Economic Affairs | General Government | Corporate Officer/Principal | |
Ten Have Change Management | Founder | ||
The Medicines Company (Schweiz) GmbH | Corporate Officer/Principal | ||
Acerta Pharma BV
![]() Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Founder | |
PEIXIN INTERNATIONAL GROUP N.V. | Industrial Machinery | Chief Administrative Officer | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Chairman | |
Institute For Netherlands Quality | Director/Board Member | ||
Kesterna BV | Corporate Officer/Principal | ||
Center For Evidence-Based Management | Chairman | ||
ATRO Medical BV
![]() ATRO Medical BV Medical SpecialtiesHealth Technology ATRO Medical BV develops trammpolin meniscus implants. The company was founded by Tony van Tienen and Jan Hunik on July 17, 2016 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Chairman | |
Stichting Instituut Nederlandse Kwaliteit
![]() Stichting Instituut Nederlandse Kwaliteit Miscellaneous Commercial ServicesCommercial Services Stichting Instituut Nederlandse Kwaliteit operates as a membership organization. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MINK THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Centre for Drug Design & Discovery
![]() Centre for Drug Design & Discovery Centre for Drug Design & Discovery is a Private Equity/Venture Capital firm, a subsidiary of KU Leuven Research & Development and founded in 2006. Centre for Drug Design & Discovery is headquartered in Leuven. | Private Equity Investor | ||
ABN AMRO Asset Based Finance N.V., Niederlassung Deutschland
![]() ABN AMRO Asset Based Finance N.V., Niederlassung Deutschland Finance/Rental/LeasingFinance ABN AMRO Asset Based Finance N.V., Niederlassung Deutschland operates a financial leasing institution. The company is based in Cologne, Germany. The German company is a subsidiary of ABN AMRO Bank N.V. and ultimately controlled by the Government of the Netherlands. The company was founded in 1990. The CEO is Kees C. van Dijkhuizen. | Finance/Rental/Leasing | Director/Board Member | |
Stichting Instituut GAK | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Cito BV
![]() Cito BV Internet Software/ServicesTechnology Services Part of Stichting Cito Instituut Voor Toetsontwikkeling, Cito BV is a Dutch company that provides tests, exams, tracking systems, certification, and research for both education and organizations. Founded in 1968, the company is based in Arnhem, Netherlands. Cito's new student tracking system, In Beeld, focuses on student growth, while their central exams provide tools and information for teachers, such as Wolf, Mix & Meet, exam reports, and more. The company is committed to providing equal opportunities for everyone. | Internet Software/Services | Chairman |
Statistiques
Internationale
Pays-Bas | 30 |
Etats-Unis | 11 |
Belgique | 5 |
Suisse | 3 |
Canada | 3 |
Sectorielle
Health Technology | 17 |
Consumer Services | 11 |
Finance | 7 |
Commercial Services | 5 |
Producer Manufacturing | 3 |
Opérationnelle
Director/Board Member | 36 |
Corporate Officer/Principal | 26 |
Chairman | 12 |
Doctorate Degree | 10 |
Chief Tech/Sci/R&D Officer | 9 |
Relations les plus connectées
- Bourse
- Insiders
- Ad W. van Gorp
- Connexions Sociétés